Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

被引:427
作者
Lewis, SJG
Foltynie, T
Blackwell, AD
Robbins, TW
Owen, AM
Barker, RA
机构
[1] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England
[2] Univ Cambridge, Dept Neurol, Cambridge CB2 1TN, England
[3] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England
[4] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[5] MRC, Cognit & Brain Sci Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
D O I
10.1136/jnnp.2003.033530
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the heterogeneity of idiopathic Parkinson's disease (PD) in a data driven among a cohort of patients in the early clinical stages of the disease meeting established criteria. Methods: Data on demographic, motor, mood, and cognitive measures were collected from consecutive patients in the early stages of PD (Hoehn and Yahr I-III) attending a specialist PD clinic. Statistical cluster analysis of the data allowed the existence of the patient subgroups generated to explored. Results: The analysis revealed four main subgroups: (a) patients with a younger disease onset; (b) a dominant subgroup of patients; (c) a non-tremor dominant subgroup with significant levels of - impairment and mild depression; and (c a subgroup with rapid disease progression but no impairment. Conclusions: This study complements and extends previous research by using a data driven define the clinical heterogeneity of early PD. The approach adopted in this study for the subgroups of patients within Parkinson's disease has important implications for generating hypotheses on defining the heterogeneity of this common condition and its aetiopathological basis thus its treatment.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 70 条
[51]   Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus [J].
Nandi, D ;
Aziz, TZ ;
Giladi, N ;
Winter, J ;
Stein, JF .
BRAIN, 2002, 125 :2418-2430
[52]   Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease [J].
Navan, P ;
Findley, LJ ;
Jeffs, JAR ;
Pearce, RKB ;
Bain, PG .
MOVEMENT DISORDERS, 2003, 18 (02) :176-180
[53]  
Nelson H. E., 1982, National Adult Reading Test
[54]   VISUOSPATIAL MEMORY DEFICITS AT DIFFERENT STAGES OF PARKINSONS-DISEASE [J].
OWEN, AM ;
BEKSINSKA, M ;
JAMES, M ;
LEIGH, PN ;
SUMMERS, BA ;
MARSDEN, CD ;
QUINN, NP ;
SAHAKIAN, BJ ;
ROBBINS, TW .
NEUROPSYCHOLOGIA, 1993, 31 (07) :627-644
[55]   DOPAMINE-DEPENDENT FRONTOSTRIATAL PLANNING DEFICITS IN EARLY PARKINSONS-DISEASE [J].
OWEN, AM ;
SAHAKIAN, BJ ;
HODGES, JR ;
SUMMERS, BA ;
POLKEY, CE ;
ROBBINS, TW .
NEUROPSYCHOLOGY, 1995, 9 (01) :126-140
[56]   FRONTO-STRIATAL COGNITIVE DEFICITS AT DIFFERENT STAGES OF PARKINSONS-DISEASE [J].
OWEN, AM ;
JAMES, M ;
LEIGH, PN ;
SUMMERS, BA ;
MARSDEN, CD ;
QUINN, NP ;
LANGE, KW ;
ROBBINS, TW .
BRAIN, 1992, 115 :1727-1751
[57]   EVIDENCE FOR A COMMON NETWORK OF BRAIN STRUCTURES INVOLVED IN PARKINSONIAN TREMOR AND VOLUNTARY REPETITIVE MOVEMENT [J].
PARKER, F ;
TZOURIO, N ;
BLOND, S ;
PETIT, H ;
MAZOYER, B .
BRAIN RESEARCH, 1992, 584 (1-2) :11-17
[58]   THE NEUROPATHOLOGIC BASIS OF DIFFERENT CLINICAL SUBGROUPS OF PARKINSONS-DISEASE [J].
PAULUS, W ;
JELLINGER, K .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1991, 50 (06) :743-755
[59]   IMPAIRED MESIAL FRONTAL AND PUTAMEN ACTIVATION IN PARKINSONS-DISEASE - A POSITRON EMISSION TOMOGRAPHY STUDY [J].
PLAYFORD, ED ;
JENKINS, IH ;
PASSINGHAM, RE ;
NUTT, J ;
FRACKOWIAK, RSJ ;
BROOKS, DJ .
ANNALS OF NEUROLOGY, 1992, 32 (02) :151-161
[60]   Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study [J].
Pogarell, O ;
Gasser, T ;
van Hilten, JJ ;
Spieker, S ;
Pollentier, S ;
Meier, D ;
Oertel, WH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06) :713-720